WASHINGTON – The Office of the United States Trade Representative today announced the extension of 77 of the 81 COVID-related exclusions in the China Section 301 Investigation. The exclusions were previously scheduled to expire on May 15, 2023. The exclusions have been extended through September 30, 2023, which will allow the United States Trade Representative to continue to consider stakeholder and public feedback. The U.S. Trade Representative is extending all 81 COVID-related exclusions, through May 31, 2023, to allow for a transition period.
The COVID exclusions, which cover medical-care products, were initially granted in December 2020. Additional information is set out in the Federal Register notice, which can be viewed here.